Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 37, 2007 - Issue 4
232
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Comparison of cerebral pharmacokinetics of buprenorphine and norbuprenorphine in an in vivo sheep model

, , , , &
Pages 441-457 | Received 08 Jan 2007, Accepted 31 Jan 2007, Published online: 22 Sep 2008

References

  • Avdeef A, Barrett DA, Shaw PN, Knaggs RD, Davis SS. Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates. Journal of Medicinal Chemistry 1996; 39: 4377–4381
  • Boas RA, Villiger JW. Clinical actions of fentanyl and buprenorphine. The significance of receptor binding. British Journal of Anaesthesia 1985; 57: 192–196
  • Budd K, Raffa RB. Buprenorphine—the unique opioid analgesic. Georg Thieme Verlag, Stuttgart 2005
  • Cowan A, Friderichs E, Strassburger W, Raffa RB. Basic pharmacology of buprenorphine. Buprenorphine—the unique opioid analgesic, K Budd, RB Raffa. Georg Thieme Verlag, Stuttgart 2005
  • Dahan A, Yassen A, Romberg R, Sarton E, Teppema L, Olofsen E, Danhof M. Buprenorphine induces ceiling in respiratory depression but not in analgesia. British Journal of Anaesthesia 2006; 96: 627–632
  • Doolette DJ, Upton RN, Grant C. Agreement between ultrasonic Doppler venous outflow and Kety and Schmidt estimates of cerebral blood flow. Clinical and Experimental Pharmacology and Physiology 1999; 26: 736–740
  • Foster DJ, Upton RN, Somogyi AA, Grant C, Martinez A. The acute disposition of (R)- and (s)-methadone in brain and lung of sheep. Journal of Pharmacokinetics and Pharmacodynamics 2005; 32: 547–570
  • Foster DJ, Jensen ML, Upton RN, Somogyi AA, Grant C, Martinez A. Blood–brain equilibration kinetics of levo-alpha-acetyl-methadol using a chronically instrumented sheep preparation. British Journal of Pharmacology 2006; 147: 209–217
  • Galtier P, Alvinerie M. Pharmacological basis for hepatic drug metabolism in sheep. Veterinary Research 1996; 27: 363–372
  • Heel RC, Brogden RN, Speight TM, Avery GS. Buprenorphine: A review of its pharmacological properties and therapeutic efficacy. Drugs 1979; 17: 81–110
  • Huang P, Kehner GB, Cowan A, Liu-Chen LY. Comparison of pharmacological activities of buprenorphine and norbuprenorphine: Norbuprenorphine is a potent opioid agonist. Journal of Pharmacology and Experimental Therapeutics 2001; 297: 688–695
  • Iribarne C, Picart D, Dreano Y, Bail JP, Berthou F. Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes. Life Sciences 1997; 60: 1953–1964
  • Kuhlman Jr JJ, Levine B, Johnson RE, Fudala PJ, Cone EJ. Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine. Addiction 1998; 93: 549–559
  • Leow KP, Cramond T, Smith MT. Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain. Anesthesia and Analgesia 1995; 80: 296–302
  • Liu X, Smith BJ, Chen C, Callegari E, Becker SL, Chen X, Cianfrogna J, Doran AC, Doran SD, Gibbs JP, et al. Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: An experimental analysis of the role of blood–brain barrier permeability, plasma protein binding, and brain tissue binding. Journal of Pharmacology and Experimental Therapeutics 2005; 313: 1254–1262
  • Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. Journal of Pharmacology and Experimental Therapeutics 1976; 197: 517–532
  • Maurer TS, Debartolo DB, Tess DA, Scott DO. Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice. Drug Metabolism and Disposition 2005; 33: 175–181
  • Mégarbane B, Marie N, Pirnay S, Borron SW, Gueye PN, Risède P, Monier C, Noble F, Baud FJ. Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation. Toxicology and Applied Pharmacology 2006; 212: 256–267
  • Michenfelder JD. Cerebral blood flow and metabolism. Clinical neuroanesthesia, RF Cucchiara, JD Michenfelder. Churchill Livingstone, MelbourneAustralia 1990
  • Moffat AC, Osselton MD, Widdop B. Clarke's analysis of drugs and poisons3rd. Pharmaceutical Press, London 2004
  • Ohtani M, Kotaki H, Sawada Y, Iga T. Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling. Journal of Pharmacology and Experimental Therapeutics 1995; 272: 505–510
  • Ohtani M, Kotaki H, Nishitateno K, Sawada Y, Iga T. Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine. Journal of Pharmacology and Experimental Therapeutics 1997; 281: 428–433
  • Picard N, Cresteil T, Djebli N, Marquet P. In vitro metabolism study of buprenorphine: Evidence for new metabolic pathways. Drug Metabolism and Disposition 2005; 33: 689–695
  • Plummer JL, Cmielewski PL, Reynolds GD, Gourlay GK, Cherry DA. Influence of polarity on dose-response relationships of intrathecal opioids in rats. Pain 1990; 40: 339–347
  • Polettini A, Huestis MA. Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine-glucuronide in plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography. B, Biomedical Sciences and Applications 2001; 754: 447–459
  • Pontani RB, Vadlamani NL, Misra AL. Disposition in the rat of buprenorphine administered parenterally and as a subcutaneous implant. Xenobiotica 1985; 15: 287–297
  • Roy SD, Roos E, Sharma K. Transdermal delivery of buprenorphine through cadaver skin. Journal of Pharmaceutical Sciences 1994; 83: 126–130
  • Runciman WB, Ilsley AH, Mather LE, Carapetis R, Rao MM. A sheep preparation for studying interactions between blood flow and drug disposition. I: Physiological profile. British Journal of Anaesthesia 1984; 56: 1015–1028
  • Scott JC, Cooke JE, Stanski DR. Electroencephalographic quantitation of opioid effect: Comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology 1991; 74: 34–42
  • Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991; 74: 53–63
  • Sicard K, Shen Q, Brevard ME, Sullivan R, Ferris CF, King JA, Duong TQ. Regional cerebral blood flow and BOLD responses in conscious and anesthetized rats under basal and hypercapnic conditions: Implications for functional MRI studies. Journal of Cerebral Blood Flow and Metabolism 2003; 23: 472–481
  • Upton RN. An analysis of errors arising from the direct use of mass balance principles to describe regional drug uptake and elution. Journal of Pharmacokinetics and Biopharmaceutics 1994; 22: 309–321
  • Upton R, Grant C, Ludbrook G. An ultrasonic Doppler venous outflow method for the continuous measurement of cerebral blood flow in conscious sheep. Journal of Cerebral Blood Flow and Metabolism 1994; 14: 680–688
  • Upton RN, Ludbrook GL, Gray EC, Grant C. The cerebral pharmacokinetics of meperidine and alfentanil in conscious sheep. Anesthesiology 1997a; 86: 1317–1325
  • Upton RN, Semple TJ, Macintyre PE. Pharmacokinetic optimisation of opioid treatment in acute pain therapy. Clinical Pharmacokinetics 1997b; 33: 225–244
  • Upton RN, Ludbrook GL, Grant C, Doolette DJ. The effect of altered cerebral blood flow on the cerebral kinetics of thiopental and propofol in sheep. Anesthesiology 2000; 93: 1085–1094
  • Upton RN, Ludbrook GL, Martinez AM, Grant C, Milne RW. Cerebral and lung kinetics of morphine in conscious sheep after short intravenous infusions. British Journal of Anaesthesia 2003; 90: 750–758
  • Van Crugten JT, Sallustio BC, Nation RL, Somogyi AA. Renal tubular transport of morphine, morphine-6-glucuronide, and morphine-3-glucuronide in the isolated perfused rat kidney. Drug Metabolism and Disposition 1991; 19: 1087–1092
  • Villesen HH, Foster DJ, Upton RN, Somogyi AA, Martinez A, Grant C. Cerebral kinetics of oxycodone in conscious sheep. Journal of Pharmaceutical Sciences 2006; 95: 1666–1676
  • Villiger JW, Taylor KM. Buprenorphine: Characteristics of binding sites in the rat central nervous system. Life Sciences 1981; 29: 2699–2708
  • Wisner D, Busche F, Sturm J, Gaab M, Meyer H. Traumatic shock and head injury: Effects of fluid resuscitation on the brain. Journal of Surgical Research 1989; 46: 49–59
  • Yassen A, Olofsen E, Dahan A, Danhof M. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: Role of receptor equilibration kinetics. Journal of Pharmacology and Experimental Therapeutics 2005; 313: 1136–1149
  • Yassen A, Olofsen E, Romberg R, Sarton E, Danhof M, Dahan A. Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers. Anesthesiology 2006; 104: 1232–1242
  • Yue H, Borenstein MR, Jansen SA, Raffa RB. Liquid chromatography-mass spectrometric analysis of buprenorphine and its N-dealkylated metabolite norbuprenorphine in rat brain tissue and plasma. Journal of Pharmacological and Toxicological Methods 2005; 52: 314–322

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.